Share
3,738 Posts.
lightbulb Created with Sketch. 607
clock Created with Sketch. 29/05/17
09:16
Share
Originally posted by The other one
↑
Hi Prestonian. Our superannuation system makes us an attractive place to float for some of these companies I gather. Now and then you hear of people considering their biotech investments as almost a charitable donation. Helps with patience I guess. Biotechs will go in and out of fashion fairly regularly but a few now seem to be getting close to a level of maturity where they have cash to complete what they want to achieve and are actually turning money away. When we see one of these do a big deal we will likely see more interest in the sector as people seek out 'the next Nanosonics' (replace NAN with whatever the next successful stock turns out to be). With capital raisings I am usually happy to trade the new shares if a good profit turns up. 30% is my benchmark. Sometimes it works out well, other times I should have held on. If the issue is poorly supported I'm in trouble. Trading the stock lets me go again, for the most part in small parcels.
Expand
If I hadn't already invested in Dimerix, I would probably wait until the results are out, given where the share price is now. As I invested a while ago I get the CGT discount, so I'm happy to be a holder into the results. The current market depth and the selling over the past few months indicates that there may still be sellers (and therefore good buying opps) even after results. Not that long to wait now.
(20min delay)